US Patent 10472425 Stabilized formulations containing anti-PCSK9 antibodies
Patent 10472425 was granted and assigned to Regeneron Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 24, 2017
Date of Patent
November 12, 2019
Patent Applicant
Patent Application Number
15603732
Patent Citations Received
Patent Inventor Names
Daniel B. Dix
0
Scott M. Walsh
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10472425 Stabilized formulations containing anti-PCSK9 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
